Literature DB >> 7871843

Transrectal ultrasonography in preoperative staging of rectal cancer.

N K Kim1, J S Choi, S K Sohn, J S Min.   

Abstract

A precise knowledge of the depth of invasion of tumor is essential for the planning of treatment of rectal cancer. Transrectal ultrasonography is a new diagnostic modality that has become useful in determining the depth of invasion preoperatively and the presence or absence of metastatic lymph nodes. Transrectal ultrasonography was used in preoperative staging of 36 patients with rectal cancer. Thirty three patients had a radical resection (17 low anterior resection, 15 abdominoperineal resection and 1 pelvic exenteration), one patient had a local excision. Two among these thirty four patients had preoperative radiotherapy. Preoperative transrectal ultrasonographic staging was compared with pathologic findings. In staging depth of invasion, the overall accuracy was 88.8 percent, overstaged in 5.8 percent, understaged in 5.8 percent. Transrectal ultrasonography is the more accurate method than CT in staging of depth of tumor invasion (61.8% vs 88.8%). In staging of lymph nodes, the overall accuracy of transrectal ultrasonography was 85.3 percent, sensitivity was 71.7 percent and specificity was 88.8 percent. Transrectal ultrasonography is a safe, inexpensive and accurate staging method in the assessment of both depth of invasion and nodal status.

Entities:  

Mesh:

Year:  1994        PMID: 7871843     DOI: 10.3349/ymj.1994.35.4.396

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  2 in total

1.  Role of Transrectal Ultrasound in Preoperative Local Staging of Carcinoma Rectum and It's Histopathological Correlation.

Authors:  Surendra Patel; Rajendra Soni; K C Gupta; Jagdish Sharma; Kusum Meena
Journal:  Indian J Surg       Date:  2012-06-16       Impact factor: 0.656

2.  Preoperative staging of rectal carcinoma by endorectal ultrasound: is there a learning curve?

Authors:  S A Badger; P B Devlin; P J D Neilly; R Gilliland
Journal:  Int J Colorectal Dis       Date:  2007-02-09       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.